Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
about
Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 yearsFactors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis.Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
P2860
Q36477420-46B9D129-5C16-4583-B585-23C6ABEE38A4Q36757435-5E729072-6934-4834-9DCC-0B42EF48103FQ44604426-A8F5D515-D105-4EEF-AFCE-8C6F03D101E3Q47276595-B0E375A4-5376-4A11-952A-826AA34DB0C0Q47367453-85827E0F-3BFB-4274-B5F7-46ED8A93AE13Q47861250-42ACA4EC-A079-4962-8E44-2B881EF7B103Q48599341-263A2FBA-0590-4439-9BD6-4C3415E6D1EFQ50086845-F1C811D6-58A6-44CA-9B39-92C6B6AF2480Q54031443-DA191554-296E-482F-A38F-729A85A38BEC
P2860
Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tocilizumab induces corticoste ...... patients in clinical practice.
@en
Tocilizumab induces corticoste ...... patients in clinical practice.
@nl
type
label
Tocilizumab induces corticoste ...... patients in clinical practice.
@en
Tocilizumab induces corticoste ...... patients in clinical practice.
@nl
prefLabel
Tocilizumab induces corticoste ...... patients in clinical practice.
@en
Tocilizumab induces corticoste ...... patients in clinical practice.
@nl
P2093
P2860
P356
P1433
P1476
Tocilizumab induces corticoste ...... patients in clinical practice.
@en
P2093
Béatrice Pallot Prades
Christian Jorgensen
Clémentine Fortunet
Elodie Constant
Hervé Devilliers
Jean Francis Maillefert
Joseph Lambert
Marie Godfrin-Valnet
Philippe Gaudin
Yves-Marie Pers
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEU339
P577
2014-09-22T00:00:00Z